The potential for HA to modulate the PDAC TME is also supported by our work identifying the direct effect of sEVs from HA-expressing tumor cells on normal monocytes where HA depletion resulted in a switch from hyperinflammatory (IL-1β) to a chemotactic (MIP1β) cytokine production. The gene discussed is CCL4; the disease is neoplasm.